基于国际竞争力视角的我国医药制造业结构性分析  

作　　者：黄佩红[1] 

机构地区：[1]华南师范大学经济管理学院,广东广州510006

出　　处：《黑龙江对外经贸》2008年第1期6-9,共4页Heilongjiang Foreign Economic Relations and Trade

摘　　要：理论界有些观点认为中国医药制造业的国际竞争力不断增强,并持较乐观的态度。文章通过实证分析却得出相反的结论:从2000年到2004年,大部分药品的贸易竞争力不断下降;同时,随着我国加入WTO和全球市场竞争日益激烈,我国医药制造业的竞争优势不稳定,并且日趋减弱,甚至消失。可见我国医药制造业的竞争力不容乐观,应引起我们的高度重视。Some scholars think that international competitiveness of Chinese pharmaceutical industry continuously enhances and feel optimistic for it. This paper has carried an empirical analysis and reached the opposite conclusion. From 2000 to 2004, the international competitiveness of most of drugs has been falling. Meanwhile, with the entrance to the WTO and fierce global market competition, the competitive advantage of our country＇ s pharmaceuti- ca/industry becomes volatile and weakening, or even disappears. This paper shows the pharmaceutical industry＇ s competitiveness is not optimistic and we should draw our attention.

关 键 词：医药制造业 国际竞争力 贸易竞争指数 

分 类 号：F42[经济管理—产业经济]